BetterScholar BetterScholar
11
Role
Title
Level Year L/R
🐜 Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine.
7 auth. A. Bradwell, H. Carr-Smith, G. Mead, Lian X. Tang, P. Showell, M. Drayson, ... R. Drew
9 2001
9
🐜
🐬 Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma.
M. Drayson, Lian X. Tang, R. Drew, G. Mead, H. Carr-Smith, A. Bradwell
8 2001
8
🐬
🐜 Quantitative assessment of serum and urinary polyclonal free light chains in patients with chronic kidney disease.
7 auth. C. Hutchison, S. Harding, P. Hewins, G. Mead, J. Townsend, A. Bradwell, ... P. Cockwell
8 2008
8
🐜
🐬 Serum test for assessment of patients with Bence Jones myeloma
A. Bradwell, H. Carr-Smith, G. Mead, T. C. Harvey, M. Drayson
8 2003
8
🐬
🐜 Efficient removal of immunoglobulin free light chains by hemodialysis for multiple myeloma: in vitro and in vivo studies.
13 auth. C. Hutchison, P. Cockwell, S. Reid, K. Chandler, G. Mead, J. Harrison, J. Hattersley, N. Evans, M. Chappell, M. Cook, ... H. Goehl, M. Storr, A. Bradwell
8 2006
8
🐜
🐢 Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure
9 auth. C. Hutchison, T. Plant, M. Drayson, P. Cockwell, M. Kountouri, K. Basnayake, ... S. Harding, A. Bradwell, G. Mead
7 2008
7
🐢
🦁 Serum free light chains for monitoring multiple myeloma
G. Mead, H. Carr-Smith, M. Drayson, Gareth J. Morgan, J. A. Child, A. Bradwell
7 2004
7
🦁
🐜 Use of nonclonal serum immunoglobulin free light chains to predict overall survival in the general population.
11 auth. A. Dispenzieri, J. Katzmann, R. Kyle, D. Larson, T. Therneau, C. Colby, ... R. Clark, G. Mead, Shaji K. Kumar, L. Melton, S. Rajkumar
7 2012
7
🐜
🐢 Assessment of monoclonal gammopathies by nephelometric measurement of individual immunoglobulin kappa/lambda ratios.
7 auth. A. Bradwell, S. Harding, N. Fourrier, G. Wallis, M. Drayson, H. Carr-Smith, ... G. Mead
7 2009
7
🐢
🦁 The separation of insect haemocyte types on Percoll gradients; methodology and problems
G. Mead, N. Ratcliffe, L. Renwrantz
6 1986
6
🦁
🐜 Hormonal and biochemical normalization and tumor shrinkage induced by anti-parathyroid hormone immunotherapy in a patient with metastatic parathyroid carcinoma.
8 auth. D. Betea, A. Bradwell, T. C. Harvey, G. Mead, H. Schmidt-Gayk, B. Ghaye, ... A. Daly, A. Beckers
6 2004
6
🐜